Icon
+91 94997 68112
Login Register

Ilevro - (0.3%; Suspension/Drops, Ophthalmic)

Nepafenac Novartis
0.3%; Suspension/Drops, Ophthalmic
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
 None
None None
Indicated for the treatment of pain and inflammation associated with cataract surgery.
Yes
**** ** *** ***** ** **** **** ** **** ******* '*** (*** *, ****), '*** (*** *, ****), '*** (***** **, ****) *** *** ************ *********. ****** *** ****** ** ** ****** ****, ********** *** ********* **** **** ***** *** ***** ** ********* *** *** *****. ** ****** **** ** ****** ***** ****** ** ****** '***(*** *, ****) ** ****** '*** ** *********** ** ****** ******. *** ******* ** **** ******* ** ** ** * ******* ***** *********** ** **** *** **** **** ******** *** ******** ******** ****** ** ***** **************.
Ilevro Patent 1 Patent 2 Patent 3
**** ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** *** \ ** **** **, **** ******* **** ***** **** *, **** (***** ******)
  1. *** **, **** : **** ** *** ***** ** ******.
  2. *** **, **** : **** (******) ******** ***** ***** *** **** ** **** ******* '*** (*** *, ****), '*** (*** *, ****) '*** (***** **, ****).
  3. *** *, **** : ***** ***** * **** ******* ****** ** ******** ***** ** ********.
  4. *** **, **** : ********** ********* **** **** ***** *** ***** ** ********* *** *** *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.